Suspected Mexican drug trafficker Juan Jose Esparragoza Monzon, aka El Negro, reportedly escaped from a prison in the city of Culiacan in northwest Mexico’s Sinaloa state on Thursday afternoon.
Monzon, who was captured January 19, is the son of Juan Jose Esparragoza Moreno, who is a longtime partner of Joaquin “El Chapo” Guzman in the upper echelon of the Sinaloa cartel.
Moreno, known as El Azul, is believed to be a major player in the cartel but has remained out of the public view. Rumors have recently emerged that he died of a heart attack in 2014.
You've reached your daily free article limit.
Subscribe and support our veteran writing staff to continue reading.
Suspected Mexican drug trafficker Juan Jose Esparragoza Monzon, aka El Negro, reportedly escaped from a prison in the city of Culiacan in northwest Mexico’s Sinaloa state on Thursday afternoon.
Monzon, who was captured January 19, is the son of Juan Jose Esparragoza Moreno, who is a longtime partner of Joaquin “El Chapo” Guzman in the upper echelon of the Sinaloa cartel.
Moreno, known as El Azul, is believed to be a major player in the cartel but has remained out of the public view. Rumors have recently emerged that he died of a heart attack in 2014.
Monzon reportedly broke out with four other high-danger prisoners, and all of them are believed to be connected to the Sinaloa cartel.
According to Sinaloa-based newspaper Rio Doce, the alarm was sounded at 12:30 p.m. on Thursday, calling for support from three levels of government. Two hours later, a search operation began around the prison but did not locate Monzon or his fellow escapees.
Read the whole story from Business Insider.
Featured image courtesy of the Mexican National Security Commission
Can China’s New Fujian Super Carrier Rival the USS Ford?
US Navy Ramps Up Virginia-Class Submarine Production
Former US Army Soldier Sentenced To 14 Years in Prison For Attempting to Aid ISIS
Former Delta Operator Geo Hand Takes Over The Cellblock
North Korea Shuts Down Unification, Demolishes Inter-Korean Roads
Join SOFREP for insider access and analysis.
TRY 14 DAYS FREEAlready a subscriber? Log In
COMMENTS
You must become a subscriber or login to view or post comments on this article.